A new approach, published in “Cell Reports,” to regenerate inner ear sensory hair cells is said to lay the groundwork for treating chronic noise-induced hearing loss by the company, Frequency Therapeutics, and its co-founders who are drawing on research from Brigham and Women's Hospital (BWH), Harvard Medical School, Mass Eye and Ear Infirmary, and MIT. The program is expected to progress to into human clinical trials within the next 18 months.
Like all healthcare fields where the clinician needs to explain complex concepts to the lay public, metaphors are used. In the optical field, “nearsighted” and “farsighted” are actually good metaphors despite their simplicity and academic inaccuracy. In the field of audiology, we have the description of the audiogram with the piano keyboard across the top; a good explanation, but limited in that it’s only the right hand side of the keyboard and musical notes are not pure-tones.
“Our results suggest that tinnitus will likely get louder, but not by very much,” write Hashir Aazh, PhD, and Richard Salvi, PhD, in their recent study published in the Journal of the American Academy of Audiology which shows only a weak association between tinnitus loudness and puretone average (PTA) thresholds.
BlueWing and CounselEAR will collaborate to create customer profiles from CounselEAR’s breadth of client databases, utilizing BlueWing’s data science expertise to facilitate a more intuitive flow of information.